Modulus Therapeutics
Seattle, US · Founded 2020 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
BR
Bryce R DainesExecutive Officer, Director
MC
Max C DarnellExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.8MraisedJul 2021 · 9 investors · BiotechnologyRule 506(b)
▶$3.8MraisedJul 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bryce R DainesExecutive Officer, Director
- Max C DarnellExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- Minimum investment
- $125K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.